Anixa Biosciences ANIX
NASDAQ ANIX
$2.74 -0.09 (-3.32%)
As of: Sep 10, 2026 · 10:48 AM EDT

Anixa Biosciences (ANIX) EPS (Diluted) (2014 - 2026)

Analysis

Anixa Biosciences (ANIX) EPS (Diluted) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Krystal Biotech 10.25 Bn 9.40 Bn 112.79 Mn 1.79
2 CRISPR Therapeutics AG 5.06 Bn 5.06 Bn - -0.94
3 Iovance Biotherapeutics 3.74 Bn 3.45 Bn 55.72 Mn -0.11
4 Legend Biotech 3.58 Bn 2.62 Bn 251.50 Mn 0.42
5 uniQure 3.01 Bn 3.01 Bn 5.49 Mn -1.22
6 Beam Therapeutics 2.54 Bn 2.54 Bn - -1.18
7 Precigen 2.37 Bn 2.37 Bn 52.17 Mn 0.05
8 Sarepta Therapeutics 2.21 Bn 1.42 Bn 251.87 Mn -0.05
9 Vericel 1.95 Bn 1.79 Bn 56.40 Mn 0.04
10 Anixa Biosciences 91.91 Mn 91.91 Mn - -0.08
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -0.08
Oct 31, 2025 -0.08
Jul 31, 2025 -0.07
Apr 30, 2025 -0.09
Jan 31, 2025 -0.10
Oct 31, 2024 -0.09
Jul 31, 2024 -0.10
Apr 30, 2024 -0.10
Jan 31, 2024 -0.10
Oct 31, 2023 -0.09
Jul 31, 2023 -0.08
Apr 30, 2023 -0.07
Jan 31, 2023 -0.08
Oct 31, 2022 -0.12
Jul 31, 2022 -0.09
Apr 30, 2022 -0.12
Jan 31, 2022 -0.13
Oct 31, 2021 -0.14
Jul 31, 2021 -0.14
Apr 30, 2021 -0.08